c-Src Promotes Tumorigenesis and Tumor Progression by Activating PFKFB3
Huanhuan Ma,Jia Zhang,Lin Zhou,Shixiong Wen,Hsiang-Yu Tang,Bin Jiang,Fengqiong Zhang,Muhammad Suleman,Dachao Sun,Ai Chen,Wentao Zhao,Furong Lin,Ming-Tong Tsau,Lu-Min Shih,Changchuan Xie,Xiaotong Li,Donghai Lin,Li-Man Hung,Mei-Ling Cheng,Qinxi Li
DOI: https://doi.org/10.1016/j.celrep.2020.03.005
IF: 8.8
2020-01-01
Cell Reports
Abstract:Reprogramming of glucose metabolism is a key event in tumorigenesis and progression. Here, we show that active c-Src stimulates glycolysis by phosphorylating (Tyr194) and activating PFKFB3, a key enzyme that boosts glycolysis by producing fructose-2,6-bisphosphate and activating PFK1. Increased glycolysis intermediates replenish non-oxidative pentose phosphate pathway (PPP) and serine pathway for biosynthesis of cancer cells. PFKFB3 knockout (KO) cells and their counterpart reconstituted with PFKFB3-Y194F show comparably impaired abilities for proliferation, migration, and xenograft formation. Furthermore, PFKFB3-Y194F knockin mice show impaired glycolysis and, mating of these mice with APC(min/+) mice attenuates spontaneous colon cancer formation in APC(min/+) mice. In summary, we identify a specific mechanism by which c-Src mediates glucose metabolism to meet cancer cells' requirements for maximal biosynthesis and proliferation. The PFKFB3-Tyr194 phosphorylation level highly correlates with c-Src activity in clinical tumor samples, indicating its potential as an evaluation for tumor prognosis.